The Johnson & Johnson vaccine, perhaps more than any other COVID shot, knows what it is to be bullied... Tweets, memes, and listicles dragged it... The underdog dose, the “second class” shot, the nation’s vaccine-a non grata, seemed as good as dead... It’s still early, but [immunologist] Collier thinks the dynamics might look a bit different for people who got a single dose of J&J. Her recent work shows that their antibody levels start significantly lower than mRNA recipients’, but that eight months out from vaccination, the numbers have stayed stable, and have, perhaps, even gone up.